Results 101 to 110 of about 188,688 (357)

Diverse Pseudomonas Species Engage in Beneficial and Suppressive Interactions with the Kiwifruit Pathogen Pseudomonas syringae pv. actinidiae Across Actinidia Germplasm

open access: yesPhytobiomes Journal
In 2010, a Pseudomonas syringae pv. actinidiae biovar 3 (Psa3) incursion into New Zealand devastated susceptible kiwifruit (Actinidia chinensis) orchards.
Haileigh R. Patterson   +3 more
doaj   +1 more source

Why blu-ray vs. HD-DVD ist not VHS vs. Betamax: the co-evolution of standard-setting consortia [PDF]

open access: yes
Extensive research has been conducted on the economics of standards in the last three decades. To date, standard-setting studies emphasize a superior role of demand-side-driven technology diffusion; these contributions assume the evolution of a user ...
Christ, Julian P., Slowak, André P.
core  

Large‐scale bidirectional arrayed genetic screens identify OXR1 and EMC4 as modifiers of αSynuclein aggregation

open access: yesFEBS Open Bio, EarlyView.
Activation of the mitochondrial protein OXR1 increases pSyn129 αSynuclein aggregation by lowering ATP levels and altering mitochondrial membrane potential, particularly in response to MSA‐derived fibrils. In contrast, ablation of the ER protein EMC4 enhances autophagic flux and lysosomal clearance, broadly reducing α‐synuclein aggregates.
Sandesh Neupane   +11 more
wiley   +1 more source

Designing probiotic therapies with broad-spectrum activity against a wildlife pathogen [PDF]

open access: yes, 2019
Host-associated microbes form an important component of immunity that protect against infection by pathogens. Treating wild individuals with these protective microbes, known as probiotics, can reduce rates of infection and disease in both wild and ...
Antwis, RE   +3 more
core   +2 more sources

Prognostic Impact of European LeukemiaNet Genetic Risk Stratification System in Adult Patients With Acute Myeloid Leukemia

open access: yesAging and Cancer, EarlyView.
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha   +4 more
wiley   +1 more source

Partner Power: A study of two distance education consortia

open access: yesInternational Review of Research in Open and Distributed Learning, 2006
This research reports findings from a study which explored the process and criteria of partner selection – how and why partners are chosen – for two distance education consortia.
Anne Banks Pidduck, Tom Carey
doaj  

School Effectiveness Grant and Pupil Deprivation Grant 2012–2013 [PDF]

open access: yes, 2012
"This is a guidance document for schools, local authorities and education consortia in Wales on the School Effectiveness Grant and Pupil Deprivation Grant.

core  

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony‐Stimulating Factor‐1 Receptor‐Related Disorders

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela   +13 more
wiley   +1 more source

Comparing consortial repositories: a model-driven analysis [PDF]

open access: yes, 2009
This study aims to provide a comparative assessment of different repository consortia as a reference to inform future work in the area. A review of the literature was used to identify repository consortia, and their features were compared.
Brown, J.
core  

Shared Genetic Effects and Antagonistic Pleiotropy Between Multiple Sclerosis and Common Cancers

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epidemiologic studies have reported inconsistent altered cancer risk in individuals with multiple sclerosis (MS). Factors such as immune dysregulation, comorbidities, and disease‐modifying therapies may contribute to this variability.
Asli Buyukkurt   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy